Meticulous Research® published Active Implantable Devices Market Report In 2017. What Does That Mean For 2022?

The Global Active Implantable Devices market will grow at a CAGR of 6.7% during the forecast period to reach USD 24.02 billion by 2022, according to the latest publication from Meticulous Research®.

The global active implantable devices market is driven by increasing incidence & prevalence of cardiovascular diseases, technological advancements, increasing prevalence of neurological diseases with growing age, and expanded application of neurostimulators in chronic pain therapy. However, stringent regulations related to active implantable devices, issues related to the use of implantable medical devices, and high cost of implants along with an unfavorable reimbursement scenario is expected to hinder the growth of active implantable devices market to some extent. Further, increasing pricing pressure on market players poses a great challenge for the growth of this market.

Key Topics Covered in This Report:
1. Introduction
2. Research Methodology
3. Executive Summary
4. Market Insights
5. Active Implantable Devices Market, by Product
6. Active Implantable Devices Market, by Geography
7. Competetive Landscape

Browse In Depth Report: https://www.meticulousresearch.com/product/active-implantable-devices-market-2022/

The implantable cardioverter defibrillators (ICDs) market is further sub-segmented into transvenous ICDs and subcutaneous ICDs with transvenous ICDs accounting for the major share, owing to their wide availability & adoption worldwide, anti-tachycardia pacing feature, increasing prevalence of cardiovascular diseases, and growing demand of the implantable therapy. Transvenous implantable cardioverter defibrillator market is further segmented into biventricular ICDs/cardiac resynchronization therapy defibrillators (CRT-DS), dual-chamber ICDs, and single-chamber ICDs.

Scope of the Report:

Market by Product
• Implantable Cardioverter Defibrillators
• Transvenous Implantable Cardioverter Defibrillators
• Biventricular Implantable Cardioverter Defibrillators
• Dual-Chamber Implantable Cardioverter Defibrillators
• Single-Chamber Implantable Cardioverter Defibrillators
• Subcutaneous Implantable Cardioverter Defibrillators
• Implantable Cardiac Pacemakers
• Ventricular Assist Devices
• Implantable Heart Monitors/Insertable Loop Recorders
• Implantable hearing devices
• Neurostimulators
• Spinal Cord Stimulators
• Deep Brain Stimulators
• Sacral Nerve Stimulators
• Vagus Nerve Stimulators
• Gastric Electrical Stimulators

Market by Geography
• North America
• U.S.
• Canada
• Europe
• Germany
• France
• U.K.
• Italy
• Spain
• Rest of Europe
• Asia-Pacific
• Japan
• China
• India
• Rest of Asia-Pacific
• Rest of World
• Latin America
• Middle East and Africa

Download Sample Report On: https://www.meticulousresearch.com/download-sample-report/?cp_id=3539

Company Profiles (Business Overview, Financials, Product Portfolio, Recent Developments)
1. Medtronic Plc
2. Boston Scientific Corporation
3. BIOTRONIK SE & CO., KG
4. LivaNova Plc
5. William Demant Holding A/S
6. Cochlear Ltd.
7. Sonova Holding AG
8. MED-EL
9. Nurotron Biotechnology Co. Ltd.
10. Nuvectra Corporation
11. Abbott Laboratories

Contact info:
Khushal
Email: sales@meticulousresearch.com
Direct Lines: +1-646-781-8004 (North America)

Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, with the help of its unique research methodologies, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa regions.

Asia-Pacific

Office No-202, 203,204,205,206; 2nd Floor, Pushpak Business Hub,
Wakad, Pimpri-Chinchwad, 411057 India.

This release was published on openPR.